Research Opportunities

The Cesarman Lab is conducting work to investigate viral mechanisms of transformation and the virus-host cell interactions that are most relevant for carcinogenesis, which may provide opportunities for new treatment and diagnostic strategies. Our work is basic and translational, relying on a combination of in vitro and in vivo basic mechanistic studies and analysis of human tissue specimens and pathologic analyses. In particular, we are interested in studying how two human oncogenic herpesviruses, KSHV (HHV-8) and EBV, cause cancer and identifying targeted approaches based on this knowledge. Our areas of interest and collaborations extend beyond viral infection to study the basic cellular mechanisms of B cell lymphomas (molecular, epigenetic, immunologival, etc). Expertise on cancer research, immunology and/or virology is desirable. Interested applicants should submit a cover email and CV to Dr. Cesarman at [email protected]

This post-doctoral opportunity will emphasize implementing behavioral and clinical interventions targeting diet, physical activity, and mood states such as stress among individuals at risk or living with chronic health conditions, such as cancer. Candidates will gain the skills to conduct research addressing abnormal energy balance leading to excess adiposity in a diverse clinical and community-based population. Applicants should have excellent oral and written communication skills, strong quantitative/analytical research skills, the ability to work independently and as part of a team, and demonstrate commitment to community-engaged research and health equity. The successful candidate will be supervised by Dr. Erica Phillips.

The Giorgio Inghirami Laboratory seeks a highly motivated postdoctoral fellow (Ph.D., MD/Ph.D. or equivalent) experienced in molecular biology, tumor immunology, and T and B cell biology to elucidate the pathogenetic events leading to T-cell transformation. The laboratory is focused on dissecting the molecular mechanisms driving tumorigenesis via STAT3, using genomic and pharmacological (i.e., Protacs) strategies. We combine a battery of in vitro, in vivo, and molecular (WES, RNAs, and multi-omics) platforms to experimental models and human lymphoma samples. We aim to define functional and therapeutic liabilities and test novel drugs and immune-based strategies via humanized mice and Patient-Derived Xenografts (PDX) models. To apply, send a cover letter, cv, and three references to [email protected].

The Nam Lab is seeking post-doctoral scientists to study the development and progression of hematopoietic neoplasms using cutting-edge molecular and computational approaches. We focus on developing novel single-cell multi-omics techniques and computational algorithms to interrogate primary human tissues directly. We implement a complementary process of discovering cancer-specific signatures directly in patient samples through powerful single-cell sequencing platforms and mechanistically defining these targets through model systems for translational impact. We are recruiting (1) a wet lab-focused molecular biologists to lead single-cell genomics technology development and experiments, and (2) computational biologists to develop new algorithms for discovery in high-dimensional datasets generated by novel experimental procedures. These fully funded positions offer competitive benefits and access to subsidized Cornell housing in Manhattan and Roosevelt Island. To apply, send your CV with a list of publications, a summary of your current and future research interests, and three references to Dr. Anna Nam at [email protected].